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I. Executive Summary
Neurodevelopmental disabilities affect 3–8% of the four million babies born each year in the
U.S. alone, with known etiology for less than 25% of those disabilities. Numerous
investigations have sought to determine the role of environmental exposures in the etiology of
a variety of human neurodevelopmental disorders (e.g., learning disabilities, attention deficit-
hyperactivity disorder, intellectual disabilities) that are manifested in childhood, adolescence,
and young adulthood. A comprehensive critical examination and discussion of the various
methodologies commonly used in investigations is needed. The Hershey Medical Center
Technical Workshop: Optimizing the Design and Interpretation of Epidemiologic Studies for
Assessing Neurodevelopmental Effects from In Utero Chemical Exposure provided such a
forum for examining these methodologies. The objective of the Workshop was to develop
scientific consensus on the key principles and considerations for optimizing the design and
interpretation of epidemiologic studies of in utero exposure to environmental chemicals and
subsequent neurodevelopmental effects. (The Panel recognized that the nervous system
develops post-natally and that critical periods of exposure can span several developmental life
stages.) Discussions from the Workshop Panel generated 17 summary points representing key
tenets of work in this field. These points stressed the importance of:
• a well-defined, biologically plausible hypothesis as the foundation of in utero studies
for assessing neurodevelopmental outcomes;
• understanding of the exposure to the environmental chemical(s) of interest,
underlying mechanisms of toxicity, and anticipated outcomes;
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• the use of a prospective, longitudinal cohort design that, when possible, runs for
periods of two to five years, and possibly even longer, in an effort to assess functions
at key developmental epochs;
• measuring potentially confounding variables at regular, fixed time intervals;
• including measures of specific cognitive and social-emotional domains along with
non-cognitive competence in young children, as well as comprehensive measures of
health;
• consistency of research design protocols across studies (i.e., tests, covariates, and
analysis styles) in an effort to improve inter-study comparisons;
• emphasis on design features that minimize introduction of systematic error at all
stages of investigation: participant selection, data collection and analysis, and
interpretation of results; these would include (but not be limited to) reducing selection
bias, using double-blind designs, and avoiding post-hoc formulation of hypotheses;
• a priori data analysis strategies tied to hypotheses and the overall research design,
particularly for methods used to characterize and address confounders in any
neurodevelopmental study;
• actual quantitative measurements of exposure, even if indirect, rather than methods
based on subject recall;
• careful examination of standard test batteries to ensure that the battery is tailored to
the age group as well as what is known about the specific neurotoxic effects on the
developing nervous system;
• establishment of a system for neurodevelopmental surveillance for tracking the
outcomes from in utero exposure across early developmental time periods to
determine whether central nervous system injuries may be lying silent until
developmentally challenged;
• ongoing exploration of computerized measures that are culturally and linguistically
sensitive, and span the age range from birth into the adolescent years;
• routine incorporation of narrative in manuscripts concerning the possibility of
spurious (i.e., false positive and false negative) test results in all research reportage
(this can be facilitated by detailed, transparent reporting of design, covariates, and
analyses so that others can attempt to replicate the study);
• forthright, disciplined, and intellectually honest treatment of the extent to which
results of any study are conclusive - that is, how generalizable the results of the study
are in terms of the implications for the individual study participants, the community
studied, and human health overall;
• confinement of reporting to the actual research questions, how they were tested, and
what the study found, and avoiding, or at least keeping to a minimum, any opinions
or speculation concerning public health implications;
• education of clinicians and policymakers to critically read scientific reports, and to
interpret study findings and conclusions appropriately; and
• recognition by investigators of their ethical duty to report negative as well as positive
findings, and the importance of neither minimizing nor exaggerating these findings.
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Neurodevelopmental disabilities affect 3–8% of 4 million babies born each year in the U.S.
alone (Weiss and Landrigan, 2000). Fewer than 25% of these neurodevelopmental disabilities
have a known etiology. It is now appreciated that subtle damage that occurs to the nervous
system during early development can manifest much later in life. This makes the ability to
establish a relationship with events occurring during gestation even more challenging. In an
effort to identify the causes of neurodevelopmental disabilities, epidemiologic research is a
valuable tool that can be used to identify potential links between disease and genetic and
environmental factors. Numerous epidemiologic studies have examined potential links
between in utero or early postnatal exposure and specific chemicals (e.g., pharmaceuticals,
environmental chemicals such as lead, methylmercury, polychlorinated biphenyls [PCBs]) and
adverse developmental or behavioral effects in children (see Rice and Barone, 2000, for a recent
review). These studies have been invaluable in laying the groundwork for how such
investigations should be conducted, and provide an excellent foundation for future studies.
Given the current interest in expanding such studies to address issues related to adverse effects
of low-level exposures to environmental factors, an examination of the methodologies
commonly used would be of significant value to investigators in the design and analysis of
future studies. Such a review would assess the strengths and limitations of methodological
approaches used to date, and consider scientific and technical advances in relevant
methodologies, such as exposure assessment, neurodevelopmental assessment, interpretation
of data, and incorporation of an evidence-based approach to identify health concerns. This
review would serve to identify key methodological factors that ultimately determine the value
and strength of a study.
The Hershey Medical Center Technical Workshop: Optimizing the Design and Interpretation
of Epidemiologic Studies for Assessing Neurodevelopmental Effects From In Utero Chemical
Exposure was a one-day meeting held in conjunction with the 22nd International
Neurotoxicology Conference (Environment and Neurodevelopmental Disorders), Research
Triangle Park, North Carolina, September 2005. Within this framework, a multidisciplinary
panel was convened to discuss issues as they relate to the design, conduct, interpretation, and
dissemination of information of human studies examining the potential adverse effects from
gestational exposure to various environmental agents. The Panel was comprised of experts in
psychology, medicine, risk/exposure assessment, analytical chemistry, neuroimaging,
epidemiology, toxicology, statistics, psychiatry, pediatrics, pediatric neuropsychology, and
neurology. Each member had experience and interest in assessing the effects of environmental
chemical exposure on human development.
This Workshop was organized to discuss the important principles for detecting the effects of
environmental exposures on neurobehavioral development and to make recommendations for
the design of future studies evaluating the impact of in utero exposures. (The Panel recognized
that the nervous system develops post-natally and that critical periods of exposure can span
several developmental life stages.) The discussions were initiated by a series of questions
related to scientific methodological issues that were posed to the Panel prior to the Workshop
(see Table 1). Given that adverse effects may emerge after long latent periods, the Panel
discussed how effects that manifest as irreversible damage to the central nervous system,
progressive neurodegeneration, or subtle neurological dysfunction first appearing in
adolescence and adulthood could be considered and incorporated into study designs. The Panel
focused on identifying ‘best practices’ for such studies which often required revisiting the basic
principles underlying current epidemiological studies. The Panel did not evaluate conclusions
or findings from previous neurodevelopmental epidemiological studies related to the topic of
environmental exposure; however, discussion of focal points from such studies served the basis
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for identifying critical points for consideration in any future study designs. The outcome of
this Workshop serves to provide input for both the design of future investigations and
establishment of standards whereby one can judge the adequacy of reported studies. This report
represents a summary of the Panel deliberations, including current basic scientific tenets that
have been embraced by this field, as well as considerations for future work.
III. Study Design for Neurodevelopmental Outcomes from In Utero Exposure
Developmental epidemiological studies examining perturbations to the nervous system from
exposure to environmental factors have provided critical data for determining human heath
risks. These studies have set the framework for the design of subsequent studies. Early
observations regarding adverse effects on the fetus from maternal exposure to various agents
focused primarily on pronounced and obvious adverse outcomes from high exposure levels.
Contemporary concerns have shifted and are now focused on more subtle alterations that may
occur with low levels of exposure. Such alterations, while not overt, may have long-term impact
on human health. The evaluation of such relationships between exposure and outcome presents
a significant challenge to the investigator, especially when the effects are subtle or delayed in
manifestation. In the discussions, the Panel recognized the importance of revisiting some of
the fundamentals of neurodevelopmental epidemiology and basic critical components of study
design as they relate to studies of in utero exposure. An extensive discussion of epidemiological
study design was outside the scope of this Workshop, as was the evaluation of specific
published research.
III.A. Types of Designs
The charge to the Panel was to evaluate study design for determining an association between
in utero environmental chemical exposure and developmental outcomes in exposed children.
Given the rationale for this Workshop, the Panel focused part of the deliberations on design
strategies for examining various outcomes resulting from such in utero exposures. First and
foremost, the Panel emphasized the importance of formulating a specific hypothesis or set of
hypotheses as part of the study design. Such hypotheses should be informed by and consistent
with previous research and, whenever possible, have biological plausibility and be related to
an underlying biological mechanism. The degree of focus or specificity of the hypothesis will
depend to some extent on the number of different outcome variables. However, hypothesis
formulation is important for the design, analysis of data and interpretation of results.
The prospective longitudinal design has proven itself as one of the most useful study designs
for examining outcomes associated with in utero exposures. Challenges exist when assessing
the influence of in utero exposures on delayed manifestation of neurotoxicity, and the
longitudinal approach may be the primary approach to detect delayed adverse outcomes. The
impact of this type of study design comes from the ability to assess exposure at the beginning
of the study, with the possibility of obtaining greater accuracy. Most alternative designs require
a retrospective assessment of exposure — a useful, but less attractive option. The collection
of longitudinal data allows for the possibility of detecting subtle changes in development that
may not be apparent in cross-sectional analyses. Longitudinal assessment of both exposure and
outcome has required the development of new methods of statistical analysis that can
incorporate the resulting correlation among repeated measurements. Such methods permit the
assessment of change within individuals over time. This approach has greatly increased the
power of the statistical inference in longitudinal studies. The prospective longitudinal design
can include developmental testing and assessment of potential confounding variables at
regular, fixed time intervals, typically for a period of two to five years, and possibly even
longer. The ability to reassess or identify potential confounding variables over the course of
the study offers a unique strength to such a study design. However, as in any longitudinal study,
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the positive aspects of the extended length of the follow-up period must be balanced with the
difficulties of maintaining active subject participation. Special efforts are often required to
prevent attrition. Over time, the attrition can become systematic as opposed to random. This,
in turn, can affect the results of the data analysis. However, with a longitudinal study design,
one can actually examine the various stages of child development. Thus, it may be possible to
demonstrate subtle differences due to in utero exposure by examining rates of development,
as well as specific cognitive, motor, sensory, psychological, or other outcomes.
One design alternative is what is sometimes referred to as an historical cohort study. This
involves enrolling a group of children within a particular age window, and retrospectively
determining gestational exposure. Such assessment is difficult and will only be possible in very
special circumstances, such as when sufficiently detailed, high-quality records, or even
biological samples, are routinely available. Alternative useful designs, depending on the
questions being asked and the hypotheses being posed, are case-control or case-cohort design
(Rothman and Greenland, 1998). These designs are useful if a particular developmental
problem is of interest for which standard diagnostic procedures are available. Within a cohort
study, one can nest both case-control or case-cohort studies to take advantage of specific
diagnostic tests.
This type of design may be especially important in the study of exposure in children, where
the developmental stage may be critical in determining the ability to detect effects of
neurotoxicants or other environmental risk factors in a given cohort.
III.B. Participant Selection
The design of a particular study, will, in general, dictate the participants selected. For the
majority of studies examining in utero exposure, the basic design typically involves assessing
exposures that occur during pregnancy and outcomes that are assessed after birth. For such a
study, during an initial enrollment period a group of pregnant women is identified early in
pregnancy and both the women and children are followed longitudinally for a specified amount
of time. The overall goal of participant selection is to select a sample that mirrors the parent
population, and thus maximizes the generalizability (external validity) of an observational
study (Kalsbeek and Heiss, 2000).
If a cohort is selected completely at random, it is assumed to be representative of the population
under study. In a simple random sample, however, the possibility still exists that individuals
in certain categories would be missed, over-sampled, or under-sampled. To address this issue,
studies may rely on stratified random sampling strategies that involve the creation of mutually
exclusive and exhaustive strata (for example, based on age, ethnicity, and residence) and
selecting samples from each of those strata (Lemeshow and Stroh, 1988). The main
disadvantage of both simple and stratified random sampling methods is that they require a
complete list of the population from which a sample is drawn. One solution to this problem is
to use a cluster sampling strategy where the original lists consist of clusters, such as villages,
wards, or polling districts, rather than individuals (Kalsbeek and Heiss, 2000). Another
possibility is a two-stage design in which subjects are selected for recruitment after an initial
survey. In many instances, this initial survey would include a preliminary estimate of exposure.
Although random samples selected from well-defined sampling frames are uncommon, some
thought should be given to the available pool of subjects, and whether this represents the
population to which the results of the study should apply. More representative samples can be
obtained by using sites with different geographic locations representing different
subpopulations, as has been proposed for the National Children’s Study (http://
nationalchildrensstudy.gov/).
Amler et al. Page 6













The actual process of selecting a representative sample is an ongoing challenge in both case-
control and cohort studies. Technology, privacy laws, and regulations are severely limiting the
use of established methods of selection, such as random digit dialing (RDD) (Brogan et al.,
2001) and Department of Motor Vehicles (DMV) records (Funkhouser et al., 2000). Hospital-
based and neighborhood recruitment strategies can be time-consuming, and are more likely to
produce samples that are not representative of the general population (Wacholder et al.,
1992). Recently, large comprehensive population directories, merged from multiple sources,
have become commercially available. It has been suggested that these directories may be more
comprehensive and more cost-effective than the traditional sources of participant selection.
Supportive data are not yet available regarding their ultimate utility, and unless very diverse
sources of information are used in these directories, they may be subject to stratification bias.
III.B.1. Sources of Bias—The term selection bias refers to introduction of systematic
differences in characteristics between those who take part in (and provide data for) the study
and those of the population, resulting in lack of generalizability and possibly comparability
between groups being studied (Grimes and Schulz, 2002). By contrast, information bias occurs
from errors in obtaining the needed information (Rothman and Greenland, 1998). Examples
of bias include: inappropriate selection of controls in case-control studies, Berkson’s bias (i.e.,
when both disease and exposure are likely to be associated with hospitalization, but unrelated
to each other in the general population), differential loss to follow up in longitudinal studies,
non-response/missing data, volunteer/self-selection, and misclassification of exposure or
outcome (Gordis, 2000). To minimize selection bias in the initial recruitment, the researchers
may choose to over-sample certain population strata where there is a higher likelihood of refusal
or drop-out (Ware and Lee, 1988). Although this approach may help ensure sufficient
representation of hard-to-study groups, it does not take into consideration the issue of
differential drop-out within the over-sampled categories.
It is important to note that even well-designed studies can become subject to bias in the
implementation phase. Participants may refuse to enroll or fail to provide necessary data, or
be lost to follow up due to change in residence or lack of motivation. The refusal to participate,
failure to provide data, and loss to follow-up may be of particular concern when there is
evidence that participation and missing information are not independent of exposure and
outcome status. For example, in a large longitudinal study of children in South Africa, Richter
et al. (2004) reported that after 10 years the project had retained 70% of the cohort, with
different rates of attrition in different subpopulations. In a cohort study evaluating the
association between methylmercury exposure and neurobehavioral testing results among
Faroese children, the final dataset included approximately 63% of the eligible cohort
(Grandjean et al., 1997). This level of participation in and of itself may not introduce bias;
however, the hospital with the lowest participation (33%) had the highest median blood
mercury concentration (Grandjean and Weihe, 1993).
In those circumstances where a concern about selection bias is justified, an extra effort to recruit
a subsample of non-participants may be warranted. This allows researchers to evaluate and
quantify the differences between participants and missing subjects—including individuals lost
through attrition or non-sampled sub-populations (Caetano et al., 2003). To minimize bias due
to subject drop-out, one may: a) obtain information on family or friends as additional contacts;
b) maintain regular contact with participants; c) utilize monetary compensation; and/or d) use
methods for early identification of attrition problems for correction (Hartman, 2005).
Alternatively, one can address the potential impact of missing information during the analysis
phase of the study.
During conduct of the study, errors in the collection of the data may also be a concern. Sources
of information bias include measurement and misclassification errors, and recall bias in
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retrospective assessment. There appears to be growing consensus that bias quantification
should become an important part of the collection, analysis, and interpretation of observational
data, with an understanding that random variability is not the only important source of error
(Caetano et al., 2003;Greenland, 2005;Hernan et al. 2004;Little and Vartivarian, 2003;Maclure
and Schneeweiss, 2001). Both selection and information bias issues may be particularly
important in cohort studies, especially if existing cohorts are used in the future to test
hypotheses that were not considered at the time of the initial recruitment.
III.C. Assessment of Exposure
As noted by Rothman and Greenland (1998), “In large part, the quality of exposure
measurement will determine the validity of an environmental epidemiology study.” Exposure
assessment is clearly a critical component in these types of studies, particularly in studies of
low-level toxicant exposures. Before exposure can be assessed, it must be defined. The
definition should include an understanding of the exposure setting, the source, nature, and
context of the exposure, whether the exposure of interest is a single agent or a mixture, and the
possibility of exposure to other compounds not under study (Rothman and Greenland, 1998).
Individual exposures can be relatively constant or highly variable over time. Daily or seasonal
variability in exposure can occur as a function of location of primary residence and pattern of
daily activity including dietary preferences and cultural practices. This variability determines
the sampling interval and may necessitate the need to construct summary measurements for
analysis. Such summaries may provide a more accurate measure of total exposure than
individual measurements. In addition, the biological kinetics of a compound drive the measures
used for analysis. For many toxicants, an average daily exposure can be used; for others, the
peak exposure is more relevant. Such decisions depend upon on the nature of the specific
toxicant and the actual level and variability of exposure. Studies frequently rely on indirect
assessments using biomarkers of exposure rather than on direct exposure measurements. While
such markers can be useful, they can have the potential to be misleading and may require
additional confirmation.
While accurate exposure measures are often difficult to obtain, they are essential if one is to
interpret any statistical associations that might occur. Thus, quantitative measurements are
preferred to those relying on subject recall. While occupational or acute exposures can often
be determined with a degree of accuracy, chronic exposure to environmental toxicants can be
variable and difficult to measure accurately. In this regard, exposure assessment for many
agents is best measured prospectively during pregnancy. If applicable, a profile can be
generated for postnatal exposure and information obtained retrospectively on pre-pregnancy
exposure. The intensity of exposure must be sufficiently great and the length and frequency of
follow-up adequate so that the exposure is more likely to affect measures of outcome in the
hypothesized manner.
III.C.1. Biomonitoring—Environmental measurements (e.g., diet, soil, air) can be used to
assess exposure as part of a neurodevelopmental study. In addition, biomonitoring has been
incorporated into epidemiological studies on neurodevelopment. There have, for example, been
investigations into the relationship between neurodevelopment and concentrations of selected
environmental chemicals, primarily the persistent lipophilic chemicals, in human milk and
maternal plasma. Over the past several years, guidance on the selection and collection of
biological samples, as well as on sampling time and methods, have been developed. For
example, total serum lipids are known to vary with the stage of pregnancy and decrease after
delivery (Montes et al., 1984). Consequently, exposure to lipophilic environmental chemicals
should be adjusted for the lipid percent at the time of sample acquisition.
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Estimates of fetal exposure can be made based on maternal biological samples, such as urine,
blood, and breast milk (Barr et al., 2005;Budtz-Jørgensen et al., 2004). Levels of chemicals in
these maternal compartments, however, may not accurately reflect the actual dose to the target
tissue, including the fetal compartment. For estimating fetal exposure, sampling of amniotic
fluid, generally between 15 to 18 weeks of gestation, would be the most direct approach
available; however, this is feasible only under very specific health conditions and is not a
standard practice. In addition, this type of estimate, while accurate, would likely result in a
biased population sampling. Finally, it has not been determined how these levels relate to the
more routinely obtained maternal blood matrix.
With birth, other tissue matrices become available. These include meconium (the infant’s first
stool), umbilical cord blood, umbilical cord tissue, and the infant’s nails and hair. Meconium
starts accumulating in the fetal bowels from about 12–16 weeks gestation (Bearer, 2003) and
has been used as a viable matrix for assessing exposure to drugs of abuse (Lauria et al.,
1997;Ostrea et al., 2001), alcohol (Bearer et al., 2003), tobacco (Ostrea et al., 1994), and
environmental chemicals (Ramirez et al., 2000;Whyatt and Barr, 2001); again, the relation to
more traditional matrices has not been established. Of these matrices, cord blood is the most
common matrix monitored. It has been estimated that in the month prior to a child’s birth, about
300 quarts of blood are pumped daily from the placenta to the fetal environment. In a recent
website report, 287 chemicals were reportedly detected in cord blood (www.ewg.org/reports/
bodyburden2). The chemicals included many halogenated organic chemicals, mercury, and
polycyclic aromatic hydrocarbons. Although cord blood is exchanged with maternal blood, the
concentrations of various chemicals are not necessarily equal. For example, it is known that
that the concentration of methylmercury in fetal blood is about 1.7 time that in maternal blood
(Amin-Zaki et al., 1974). Sampling of cord blood for chlorpyrifos showed a relationship to
indoor air levels as well as outcome measures of length and weight at birth (Whyatt et al.,
2004). Burse et al. (2000) utilized umbilical cord tissue to assess in utero exposure to selected
persistent pesticides and PCBs; one of the difficulties they faced was gravimetrically
determining the low lipid content (about 0.2%) of the cords and the variable and unmeasured
presence of residual red blood cells in the vessels when the cord tissue was taken. For selenium,
Lorenzo et al. (2005) reported positive correlations between cord blood and newborns’ hair,
between placenta and umbilical cord, and between cord blood and maternal blood. For more
details on the matrices available and volumes required for assessing in utero and early
postpartum exposure, the reader is referred to Barr et al. (2005).
III.D. Assessment of Neurodevelopmental and Related Outcomes
Compared to the measurement of exposure, outcome assessment is comparatively
straightforward, since a number of standard developmental test batteries with good
psychometric properties are readily available. Since the early work of Hanninen (1966)
examining carbon disulfide exposure, the field of human behavioral neurotoxicology has
embraced a neurobehavioral approach to the assessment of outcome following exposure,
although the specific neurocognitive domains that are targeted vary from study to study. Over
a decade ago, Anger et al. (1994) provided a list of functional domains in adults that could be
affected by chemicals. These included learning and memory, coding, sustained attention,
higher intellectual function, strength, coordination, speed, vision, somatosensory function, and
affect. Over the past four decades, this assessment approach to neurodevelopmental outcomes
has been extended downward to examine very young children following their exposure in
utero and excellent outcome measures are now available across the lifespan.
One of the earlier efforts in this area came from the World Health Organization (WHO), which
recommended the use of the Neurobehavioral Core Test Battery (NCTB). This battery was
comprised of a variety of tasks including digit symbol, digit span, Benton visual retention,
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pursuit aiming II, simple reaction time, Santa Ana, and a profile of mood states. This original
conceptualization has influenced the selection of neurobehavioral tools for the past 35 years
(Anger, 2003). In the context of developing a testing strategy for the National Children’s Study,
a workshop sponsored by National Institute of Child Health and Development (NICHD) and
the Environmental Protection Agency (EPA) examined the questions of what, how, and when
to measure neurobehavioral function in children. They considered batteries of tests and stand-
alone metrics for use in longitudinal studies examining multiple functional domains. A major
emphasis in this report was placed on testing functional competence, cognitive, sensory, motor
and social/emotional development in the first four years of life (http://
nationalchildrensstudy.gov/events/workshops/Neurobehavioral_Development.cfm). Paule
(2005) also argued for task continuity across species to identify species similarities and
differences, as well as to facilitate extrapolation of experimental animal data to humans.
While NCTB has driven much of the application methodology in pediatric neurotoxicology,
its applicability to large epidemiological studies has been questioned. The direct assessment
of these tasks to exposed individuals and the use of trained personnel create a labor-intensive
situation for studying outcome. This is particularly true for large epidemiological studies and
studies where cultural and linguistic issues are present. As a result, a number of other
approaches have been employed to address these concerns. For example, in 1996 the Agency
for Toxic Substances and Disease Registry designed the Pediatric Environmental
Neurobehavioral Test Battery (PENTB) for children ages 1 to 16 years. The PENTB was
constructed for cross-sectional studies. For children younger than 4 years of age, four
informant-based scales are employed: the Parenting Stress Index (PSI), the Personality
Inventory for Children (PIC), and the Vineland Adaptive Behavior Scales (VABS). For
children ages 4 through 16, the PENTB evaluates cognitive, motor, sensory, and affective
domains (Zeitz et al., 2002).
Another approach has embraced computerized assessment strategies and a variety of these have
been developed. They require less time and expertise and provide for rapid scoring and data
entry strategies. For example, tasks for The National Center for Toxicological Research
Operant Test Battery and its variants (Paule, 1990;Paule et al., 1999) were selected based on
their association with brain functions (e.g., short-term memory, attention, learning, time
perception, motivation, color and position discrimination). For assessing older children,
Iregren and Letz (1991) suggested the use of a Minimum Common Core Computerized Battery
comprised of symbol digit, finger tapping, and simple reaction time. Otto et al. (1996) used a
computerized battery, the Neurobehavioral Evaluation System (NES2), in pediatric
neurotoxicology studies. This has been recently updated to the NES-3 (Proctor et al., 2000).
A number of other computerized batteries have been developed, including the Cambridge
Neuropsychological Test Automated Battery (CANTAB®), CogSport, HeadMinder,
ImPACT, Automated Neuropsychological Assessment Metric, Cognitive Evaluation Protocol,
and CNS Vital Signs. Other available batteries for use with both humans and non-human
primates include the National Center for Toxicological Research (NCTR) Operant Test Battery
(Paule et al., 1999) and the Behavioral Assessment and Research System (BARS) (Anger et
al., 1996). Computerized batteries have been developed which combine various facets of other
batteries (e.g., Rohlman et al., 2001). However, at present, there is no one neurobehavioral
function test battery that has been recommended across age ranges or across cultures for any
specific neurotoxic chemicals because none of the current batteries tests all functional domains
of the nervous system function. As an overall guiding principle, choice of cognitive outcome
measures should be based on the biological evidence of nervous system structural and
functional development. To illustrate, during the infancy period (birth to 2 years of age),
research suggests the developmental salience of three specific cognitive dimensions: (1) speed
of processing, as assessed on tasks like habituation and visual expectancy performance
(Colombo, 1993;Dougherty and Haith, 1997); (2) recognition memory, as assessed on tasks
Amler et al. Page 10













like novelty preference and conjugate reinforcement (Rovee-Collier and Barr, 2001;Fagen and
Ohr, 2001); and (3) behavioral inhibition, as assessed on measures like the A not B task. As
the child develops other specific cognitive processes, such as the development of selective
attention (Ruff and Rothbart, 1996), processing speed and working memory become
increasingly important (Schneider, 2002).
III.D.1. Non-Cognitive Approaches to Developmental Outcomes—The majority of
human behavioral neurotoxicology studies have focused primarily on measures of cognitive
competence in children. For example, with regard to lead, most of the human developmental
studies referenced in a recent review used measures of general cognitive function or cognitive-
related measures such as visual-motor behavior, executive function, and attention, though some
studies have reported an increased risk for anti-social behavior and impulsivity in children
(Hubbs-Tait et al., 2005). The same review also reported virtually no evidence of non-cognitive
outcomes as a function of exposure to mercury, manganese, or cadmium (Hubbs-Tait et al.,
2005).
In recent years, developmental researchers have emphasized the multi-dimensional nature of
children’s development, with specific reference to the concept of competence (Masten and
Coatsworth, 1998;Masten and Powell, 2003). In addition to the acquisition of culturally- and
age-appropriate specific cognitive abilities, the development of competence in children also
involves the acquisition of intrapersonal characteristics and interpersonal skills that help the
child to meet both major culturally salient developmental goals and to deal effectively with
environmental challenges (Yates et al., 2003). This conceptual shift to a multi-dimensional
approach to assessing children’s development in part reflects the fact that normality of
development in one domain does not necessarily mean that there will be normality across all
domains (Lester et al., 1995). A major implication of the concept of competence for research
in behavioral teratology and toxicology is the need to go beyond a primary focus on cognitive
outcomes, such as developmental quotient or IQ scores (Bellinger, 1995;Cory-Slechta,
1990;Rice, 2005;Weiss, 2000) to assess other critical developmental domains that also define
competence. Some of these domains include: 1) temperament, including reference to indices
of self-regulation and reactivity; 2) development of a secure attachment by the young child; 3)
development of motivation by the young child to be actively involved with their environment;
and 4) developing the ability to elicit and use other persons as resources and establishing
appropriate social interaction patterns with caregivers and peers (Wachs, 1999;Masten and
Powell, 2003;Werner, 1990). Children who are strong in these characteristics possess a range
of flexible coping strategies to deal with day-to-day stressors, are more likely to demonstrate
better performance in school, and are less likely to exhibit behavioral problems.
For example, one major dimension of temperament is self-regulation. This dimension of non-
cognitive competence has unique linkages to specific cognitive executive functions, and refers
to the child’s ability to control his or her own behavior and emotions (Rothbart and Bates,
2006). After the first year of life, indices of self-regulation (e.g., the ability to inhibit ongoing
behavior, selectively attending to cues, joint attention) become more stable and increasingly
influence an individual’s competence (Bates, 2001;Rothbart and Bates, 2006). Dimensions of
self-regulation in infancy and childhood can be assessed either by validated parent report
measures (e.g., Rothbart et al., 2001) or laboratory-based behavioral assessments (e.g.,
Kochanska et al., 2000). These measures have been demonstrated to be important in the context
of environmental exposures; some studies have reported self-regulation deficits in infants and
young children exposed to environmental chemicals (Burnette et al., 1999;Chasnoff et al.,
1987;Mayes and Bornstein, 1995;Mendelsohn et al., 1998). Other studies indicate that infants
exposed to certain environmental chemicals are harder to test and less likely to complete testing
due to deficits in self-regulation skills, such as high distractibility or low consolability when
distressed (Fagen and Ohr, 2001;Mayes and Bornstein, 1995;Struthers and Hansen, 1992).
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From these data, models have been developed for environmental exposure and disturbances in
the development of regulation processes (Mayes, 2002).
A recent monograph from the Institute of Medicine (2004) presents a series of criteria that can
be used to evaluate the utility of different procedures for assessing different aspects of infant
competence (e.g., age appropriateness of instrument, degree to which scores on the instrument
are predictive of later development, evidence that the instrument is sensitive to toxic exposure,
whether performance on the instrument can be linked to perturbations in brain function/brain
development). The Institute of Medicine (2004) monograph also stresses the importance of
utilization of converging measurements of the same construct (aggregation) as a means of
maximizing assessment sensitivity. The conclusions drawn in this monograph can serve as a
guide to both dimension and instrument selection when assessing both cognitive and non-
cognitive competence in early life. Choice of non-cognitive outcome measures should be based
on the biological evidence of nervous system structural and functional development.
III.E. Statistical Considerations
While a review of statistical methodologies in neurodevelopmental epidemiology studies was
beyond the scope of the Workshop, the Panel emphasized a number of fundamentals such as
the importance of laying out a statistical design for the study in advance and ensuring that the
statistical methods be transparent to the reviewer and reader. The complexity and expense of
most epidemiological studies confines them to confirming suspected associations rather than
generating new hypotheses. Consequently, the formulation of a priori hypotheses based on
prior empirical data or theoretical considerations is essential. After formulating a hypothesis,
the statistical design for the primary analysis of the study should be determined in advance.
An a priori primary analysis plan should provide the investigators the primary answer for
whether the hypothesized associations are in fact present or not. This primary analysis plan
should be adhered to and the statistical methods and results should be reported in enough detail
that they could be replicated (i.e., transparency). This minimizes the possibility of identifying
obscure effects or interactions as the result of conducting multiple tests. Secondary analyses
can then confirm the primary study or not, answer secondary questions, explicate limitations
and explore other possible associations. Secondary analyses can be very useful, but should be
identified as such. For example, there may be susceptible populations to specific environmental
chemicals. Secondary analyses of such susceptible groups can prevent a Type II error (failure
to detect a real effect when one is present because it is confined to a particular group of
individuals).
In both planning and evaluating the results of a confirmatory study, it is critical that sample
size be taken into account; if the sample size is too small, important effects on small sub-
populations can be completely masked. It is less well-recognized that small studies can also
have a greater probability of Type I errors. One solution is to take a two-prong strategy: (1)
cluster sampling, which (unlike random sampling) ensures representation of small
subpopulations; and (2) calculating sample sizes in advance, based on a priori established
probabilities of Type I and Type II errors. A sample size calculation is a prerequisite for any
confirmatory study. In addition, in order to appropriately power studies, one needs a strong
knowledge base to identify effects that should be considered. Most notable is the use of
mechanism or mode of action for any specific compound underlying a specific endpoint under
study.
III.E.1. Confounders, Covariates, Mediators, and Effect Modifiers—The goal of
environmental epidemiology is to evaluate the relationship between exposure and a disease or
other outcome. This is nearly always accomplished by the use of statistical modeling in which
the outcome (dependent variable) is modeled as a function of the exposure (independent
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variable). However, there is always a concern that factors other than the exposure could explain
an observed relationship. Epidemiologic methods rely on the appropriate use of confounder
measurements to avoid or adjust for confounders. While this appears to be rather
straightforward, assessment of not only known confounders but of determining how these and
other factors change over time and the impact of such changes become critical factors in
neurodevelopmental studies. With the expansion of studies to examine effects that occur over
a lifetime, an additional effort may be needed to identify influences not previously considered.
For these reasons, the Panel reconsidered the current terminology and definitions.
Briefly, a covariate is a variable associated with the outcome of interest. Its inclusion in the
model may increase the precision of the parameter estimates. A confounder is related to both
exposure and outcome, and affects the estimate of the association between the two. As such,
a confounder affects the estimate of the association between the two. Unless the statistical
model adjusts for such confounding variables, a biased estimate of the association can result;
either the appearance of an effect can occur where none exists or a real association can be
attenuated. There are many factors (covariates) that affect developmental outcomes, although
they are typically unrelated to exposure; however this may not be the case in every situation
and with every environmental exposure; for example some exposures may be associated with
SES.
Confounding variables that are commonly considered in studies of neurodevelopmental effects
in children include participant age, race, gender, socioeconomic status (SES), and maternal
variables such as age, education, and IQ. While each of the variables appears to be distinct, the
variables are a mix of multiple potential confounding factors. For example, while age is an
important variable in itself, it could also encompass other aspects such as the age at first
exposure, the age-period of exposure duration, or the developmental stage of the child when
exposure occurred. In addition, in the case of in utero exposure, the duration of exposure could
be significantly influenced by the pregnancy duration inclusive of premature birth. This would
influence the accumulated dose level and whether or not the exposure occurred during a normal
period of in utero development. For children, additional variables include health status,
nutrition and diet, educational experiences, and social experience. In any developmental study,
the influence of the parents on the offspring is significant. This presents as a collage of postnatal
confounders including genetic background, prenatal environment, parent/child interactions,
mental heath, home environment, and health status. For example, while SES may not be a direct
risk factor, many of the factors related to SES may increase the risk for the outcome under
study. In addition, confounders like SES are not necessarily stagnant and can change over time.
For this reason, such confounders require repeated assessment over the course of the study. In
the case of multiple confounders, evaluation of a change with or without adjustment for other
confounders can make a large difference in the final estimate. Even when adjustments are
made, one must continue to be concerned with the remaining (residual) confounding. Given
the impact of confounders in the final interpretation of the study results, it is critical that the
criteria used to select confounders for adjustment and how they were measured be reported as
part of any analysis plan.
More complicated is the potential need to differentiate between confounders and mediators. If
an intervening variable is functioning as a mediator, an indirect causal pathway is established
between exposure and outcome. In this case, the mediator serves as the mechanism through
which toxic exposure translates into biological deficits. For neurodevelopmental studies, an
example would include the case where exposure to an environmental chemical produces a
change in an infant’s temperament characteristics. Such changes could include an increased
level of irritability or a reduced level of responsiveness or attention. These, in turn, can have
a significant influence on testing performance or have other long-term behavioral consequences
(Bendersky et al., 1996;Chasnoff et al., 1987;Fried, 1989;O’Connor et al., 1993;Ruff and
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Rothbart, 1996). Under such conditions, exposure would result in negative developmental
consequences, albeit through an indirect causal pathway. Thus, treating either temperament or
patterns of parent-child relations as a confounder would not be appropriate. Given that
confounders and mediators may show the same pattern of relations with predictors and
outcomes, it is important to develop decision rules for interpretation. One such rule would
involve the degree to which one can assume a causal link between toxic exposure and mediator,
as opposed to a non-causal association. Reviews of statistical approaches to analyze for
mediator effects are outside the scope of the workshop and can be found in a number of sources
(Evans and Lepore, 1997;MacKinnon et al., 2002).
While studies often attempt to isolate the effects of a single chemical agent, exposure to
multiple environmental agents occurs in the population (Cory-Slechta, 2005;Mayes,
2002;Wachs, 2000). The level of relation between exposure to environmental chemicals and
developmental outcomes can vary systematically as a function of population characteristics
(Bellinger, 2000;Ruff, 1999). In this situation, one is dealing with effect modifier(s) or
moderating variable(s). An effect modifier modifies the effect of the exposure on disease. It is
the variation in the magnitude of any specific measure of an exposure effect as it varies across
levels of another variable. In the absence of identifying and testing for moderators, exposure-
outcome relationships can be under- or over-estimated due to the fact that the impact of such
exposure will be restricted only to a specific subgroup within the larger sample population
(Bellinger, 2000;Davidson et al., 2004;Jacobson and Jacobson, 2002;Rauh et al.,
2004;Vreugdenhil et al., 2002;Wachs and Plomin, 1991). For developmental neurotoxicology
assessments in the human population, such modifiers may become more difficult to assess as
the study duration increases and the number and types of modifiers change. How to handle
these changing dynamics within a population and within individuals of a population will be a
major challenge for future studies.
IV. Interpretation and Dissemination of Study Information
Epidemiologic studies of neurodevelopmental outcomes place extraordinary demands on the
professional, intellectual, ethical, and communicative skills of the investigators. As a part of
the standard scientific process, data obtained from one study are used to generate hypotheses
to be tested in subsequent studies. While this sequence of events, in general, serves to advance
our understanding of a process, hypotheses are just that. Quite often, hypotheses generated
from studies on the human population can have a significant impact, in and of themselves, on
the population under study. Thus, care must be exercised in the final interpretation of such data
and the future use of the data. The Panel stressed the care required in order to advance the
science while at the same time responsibly interpreting and communicating study data. For
these reasons, the Panel reiterated the need for full, open, and transparent reporting of all aspects
of a study design and analysis. In addition, the Panel encouraged the reporting of all results
with a discussion inclusive of all of the findings of a study whether they identified a relationship
or not. It was acknowledged that the reporting process requires at least as much planning, care,
and attention to detail as other aspects of study design and implementation. However, it is often
the last aspect to be considered in the effort to publish results. Ideally, report planning begins
during the study design phase; this is when the investigators decide what research questions
will be addressed and consider what conclusions might be drawn from various study outcomes
that are possible. Use of data to address questions for which the study was not designed should
proceed with caution because of the potential for misinterpretation or misattribution of the
relationship between exposure and adverse effects on the nervous system. The results of such
post hoc exploratory analysis may be hypothesis-generating, but not necessarily definitive.
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A study report reaches many audiences, each with its own core concerns and priorities. In
addition, the investigators have a responsibility to the participants of any specific study.
Investigators need to consider these constituencies in reporting their findings.
• Study participants want to know their individual results, any immediate needs for
medical or public health follow-up, and any implications for their health and well
being. They also want to know about any heightened risks to their household members
and community.
• Members of the study community want to know about any heightened risks to the
community or any of its members, and any need for public health actions or follow-
ups.
• The public at-large wants to know the public health implications of the results, and
any recommendations for public policies or regulations to protect the population.
• The scientific community wants to know the detailed methods and results, and the
investigators’ interpretation. They seek to replicate the findings, if possible, compare
the findings to those obtained by other investigators, and consider any generalizable
principles or trends suggested by the aggregated outcomes of multiple investigations.
• The sponsor or funding agency wants a coherent summary of the information that
was gained, and how that information can be used to improve and promote health,
eliminate or reduce risks, improve the environment, and protect public health.
• The investigators themselves want to understand every detail and nuance of the study
findings, to enable exhaustive analysis and maximize the quality and quantity of useful
information obtained from the study. They also want to compare their work to other
studies, translate their findings into prudent recommendations for action, and generate
hypotheses to be examined by further inquiry.
• The news media seek take-home messages, translations of the scientific information
into lay-person language, and implications for public policy.
Collective experience has been accumulated, by the authors and many others, from dozens of
environmental health studies conducted over two decades across the United States (for review,
Amler and Tinker, 1992;Friedman et al., 1999;Amler and Falk, 2000;Brauer et al.,
2004;Schwartz et al., 2006). This experience demonstrates a consistent benefit of early and
regular contact with study communities as an indispensable aid in report planning. As a part
of the responsibility of the investigators, prospective study participants, household members,
and community members can be familiarized with study objectives and study design. These
participants can learn what information can be reasonably expected from the study results.
Report planning is facilitated by the enhanced familiarity of study participants and community
with issues. This familiarity can also assist in raising concerns that are likely to surface but are
unknown to the investigator.
Results that are statistically significant may be significant only in the mathematical
probabilistic sense—that the observed outcomes were unlikely to be due to chance alone. For
example, a very small observed difference between two study groups in a neuropsychological
test result may be inconsequential in any real sense but may achieve statistical significance
simply due to the large study population or the large number of tests performed.
Because statistical significance is dependent on sample size, studies with large-sample sizes
can yield statistically significant results that have only trivial clinical importance. This implies
that results must be interpreted carefully considering at least three distinct types of conclusions
and how they will be reported: the medical implications for individual participants, the potential
health impact on the study population, and the acceptance or rejection of the study hypotheses.
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IV.A. Reporting Test Results to Individual Study Participants
A frequently encountered question is: how meaningful are study findings as they relate to
individual study participants, the community, and the general advancement of environmental
toxicology. For example, some of the non-cognitive neuropsychological tests as well as tests
for specific cognitive functions, although useful in evaluating populations, do not have well
established absolute normal values and thus must be interpreted solely in a comparison between
exposed and non-exposed groups (Amler and Gibertini, 1996). This implies that results must
be interpreted carefully considering at least three distinct types of conclusions and how they
will be reported: the medical implications for individual participants, the potential health
impact on the study population, and the acceptance or rejection of the study hypotheses.
All study participants with aberrant test results are entitled to some clinical reporting and
counseling, or at least referral to an appropriate competent medical resource. Virtually all such
individual interpretation issues are easier to manage when they are explained in advance of the
study, detailed in the informed consent documentation, and reinforced throughout the conduct
of the investigation.
Therefore, a communications plan is essential, both to alleviate concerns about test results that
are statistically at variance but not deemed abnormal or injurious, and to ensure proper reporting
of individual results that might require medical attention. Investigators must be cautious to
avoid labeling study participants, especially children, and be circumspect in reporting test
results to parents. Cognitive test results can be especially provocative because many people
equate them with intellectual ability. Although there are few empirical studies on the effects
of such labeling (Hastings, 1994;Jellison and Duke, 1994;Sparrow et al., 1993;Townsend et
al., 1993), the issue of a child's intellect is clearly emotionally charged for most parents and
families. For many, this may be the first occasion on which they are confronted with such
information, from which they often infer far-reaching implications. Without appropriate
preparation, they may be profoundly disheartened and discouraged by this information.
IV.B. Reporting Test Results to Study Communities and the Public At-Large
Communities and the public at-large, like individual study participants, are interested in
whether a study finds any real or potential health impact from the toxic exposures or hazardous
chemicals of concern, and if such effects are found, what remedies are available and
recommended. The investigators, again, must distinguish carefully between study findings that
are statistically significant merely in a probabilistic mathematical sense, and those that have
real meaning for the health of the community and the public. This is best accomplished at the
time the study protocol is developed, when the investigators should consider a priori what
effect sizes they will consider meaningful in this latter sense. Reporting of the findings should
be confined to the data as it relates to the actual research questions for which the study was
designed to address. Speculation regarding the impact of these findings without additional
supportive data should be discouraged. With regard to any individual concerns, the
investigators must be able to put the findings into perspective in that any test results detecting
differences between groups do not necessarily indicate individual abnormalities. Any
presentation of the findings should be forthright and disciplined in stating the implications for
the individual study participants, the exposed community, and human health overall.
In many instances, a small effect size can be important on a population basis even when it is
not large enough to be important for individuals. A frequently cited hypothetical example
examines the implications of a 3-point decrease in IQ scores in a population. Although a 3-
point decrease in an otherwise healthy individual is not likely to be noticeable, a 3-point decline
shifting the IQ distribution curve for an entire population might result in thousands more people
with impaired cognitive function, and thus thousands of additional people requiring
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intervention services. The same 3-point shift might also result in thousands fewer people with
exceptional cognitive ability, and perhaps most able to contribute exceptional leadership and
vision to a community. Widely published population estimates of the economic and social
impacts of lead poisoning are based on this hypothetical example. However, this hypothetical
example assumes that both tails of the IQ distribution curve are unaltered in slope and contour
by the 3-point shift. Actual effects in any real-life population would depend on a number of
variable factors, such as the pre-morbid distribution of IQ scores, and the impairing effect, if
any, of the neurotoxicant on that distribution curve, as well as the IQ-score shift itself.
The complex task of explaining fairly technical study results to communities, and helping
people put those results in proper perspective, is aided by a number of published guidelines.
Education of the health community in the interpretation of data obtained from epidemiological
studies will serve substantially in the accurate communication to the general public as well as
to the population under study. In many cases these are drawn from considerable experience in
discussing the results of environmental health studies in communities located near hazardous
waste sites. Effective principles of risk communication include early community involvement,
clear identification of quantifiable hazards, and consideration of emotional and psychological
components of risk perception (Amler and Tinker, 1992;Friedman et al., 1999;Brauer et al.,
2004). Community members are often frustrated by the absence of clear answers to highly
specific questions (e.g., “Do we have more children in special education because our water is
polluted?), but when adequately informed will often respond constructively to recommended
solutions (e.g., how to minimize exposure and thereby risk, how to detect clinical problems
early and minimize their impact) (Amler and Falk, 2000). Training of investigators in effective
methods of risk communication will be extremely helpful to this process.
IV.C. Reporting Test Results to the Scientific Community
Throughout report planning and generation, investigators must be disciplined and intellectually
honest in asking themselves: how conclusive and how generalizable are the results, were the
original study questions (and others) answered, and what are the implications for the individual
study participants, the study community, the nation, and human health overall. Discipline is
especially critical in restricting reporting to the actual research questions, how they were tested,
and what the study found. Broader speculation should be avoided or at least kept to a minimum
and clearly labeled as such. There is a parallel requirement for clinicians and policymakers to
learn how to read scientific reports and interpret study findings and conclusions. The
appropriate role of the scientist as a uniquely informed advocate for social change is a far more
complex issue and beyond the scope of this Panel. Nevertheless, all investigators have an ethical
duty to report negative as well as positive findings, and should take great care to neither
minimize or exaggerate the findings.
V. Additional Discussion Points
The Executive Summary from this Workshop condenses the discussions of the Panel into 17
specific critical points. In addition, a number of discussion points were broached by the Panel
regarding optimizing the design and interpretation of epidemiologic studies for assessing
neurodevelopmental effects from in utero chemical exposure. These included the importance
of understanding and integrating results from previous studies into the design of new
neurodevelopmental epidemiology studies. The ability to compare results across studies has
been severely limited in the past. This is not due to any specific error in design but rather only
in differences in design that prevent direct comparisons. The Panel stressed the importance of
developing and maintaining the ability to perform interstudy comparisons. While there are
“optimal” study designs, they are often not feasible to conduct and there is a need for both
small and moderate size studies to focus on a specific question in depth. This can serve to
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provide the foundation for large-scale study designs that can both confirm specific hypotheses
and generate new ones. The Panel discussed the importance of a study design that accounts for
enrichment effects, including concept of resilience.
With respect to the assessment of exposure and development of the nervous system, the
concepts of critical windows of development and of effect come into play. While identifying
critical windows would serve to significantly focus such studies, this would require previous
knowledge concerning effects occurring at a specific stage of fetal development. The Panel
emphasized that unless a critical gestational exposure window can be identified, exposure
assessment over the entire period of gestation should be considered. In addition to providing
an accurate measure of prenatal exposure, longitudinal measurements may allow identification
of an especially sensitive period during pregnancy, particularly if sufficient variability is
present.
In addition, the Panel stressed that practical considerations should be considered that affect
participant burden, such as the length of time required to administer tests and in what setting
(home or clinical setting) any testing may occur. All of these factors can influence the cost of
a comprehensive evaluation of neurobehavioral function, but the hypothesis being tested
should be the overarching determinant of what, when, and how the metrics are employed.
Consequently, the real questions apply to the ultimate purpose of the measurement, when
measurement should occur, and whether the measurement can be performed reliably. Further,
as noted earlier, there is a need for the assessment of multiple neurobehavioral processes
including measures of non-cognitive competence. For future studies, the Panel emphasized the
inclusion of all information possible into the selection of outcome measures for example
assessment of specific cognitive functions related to the development of competence in young
children. Theoretical brain-based models can be used in the development of such assessment.
Most importantly, the forward momentum for the field can be enhanced by the establishment
of a system for neurodevelopmental surveillance. This would allow for tracking the outcomes
from in utero exposure across early developmental time periods to determine whether central
nervous system injuries may be lying silent until challenged. Such efforts will significantly
improve the ability to identify those exposures that present a health risk to the fetus.
Other concepts and new directions discussed by the Panel included the examination of specific,
a priori defined susceptible populations and the use of high risk populations. The expanded
use of medical records, when possible, to confirm diagnoses, and the concept of early detection
and screening procedures, and the use of dosimetry technology were also discussed. The Panel
concluded by formulating the 17 points listed in the Executive Summary to continue to
stimulate scientific discussions on contemporary issues with respect to this important area of
inquiry.
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Table 1
Topics and Associated Questions for the Expert Panel.
Panel Topics and Questions
Study Designs
Q1: What are the components of optimal experimental design and methodologies to assess the Likelihood that in utero exposure to an environmental
chemical can result in adverse neurodevelopmental effects in newborns that continue into childhood?
Q2: What are the statistical issues that must be addressed to conclude with adequate confidence that an in utero exposure to a specific environmental
chemical can result in adverse neurodevelopmental effects?
Participant Selection
Q1: What is the most appropriate and valid way to select exposed and control groups for studies attempting to demonstrate an association between in
utero exposure to a specific environmental chemical and adverse neurodevelopmental effects?
Exposure Assessment
Q1: Which specific measurement tools and biomarkers are best suited and validated for assessing the nature, extent, and patterns of in utero exposure to
a particular environmental chemical? How might these differ from tools and biomarkers used to assess post-natal exposure?
Q2: To avoid exposure misclassification or misleading estimates when assessing potential exposure, how frequently should exposure be estimated (i.e.,
what temporal units should be used for serial exposure measurements)? If appropriate temporal units are chemical- or tissue- specific, what data or criteria
should be used to determine the optimal units? How should critical timeframes – critical windows of vulnerability in neurodevelopment - be taken into
account when designing an exposure assessment approach?
Q3: How should potential aggregate exposure from multiple routes (inhalation, ingestion, dermal) be addressed? How should potential cumulative exposure
to multiple chemicals be addressed?
Cognitive and Non-Cognitive Measurement Tools
Q1: What specific measurement tools/tests are best suited and validated for assessing the variety of potential neurodevelopmental and behavioral deficits?
What is the known sensitivity, specificity and predictive value of each endpoint being measured? How reproducible is/are the measurement(s)?
Q2: Are there particular sampling strategies or data collection methods that are especially relevant to detecting potential neurodevelopmental effects from
in utero exposure? What sampling and analysis strategies can be employed to avoid Type II (failure to detect a real effect) errors?
Q3: What is the relationship between the estimated window of exposure and the nature of a potential effect, and how might this affect the selection of
tests?
Q4: How might data and methods from the field of molecular epidemiology be used to enhance traditional epidemiologic approaches?
Statistical Issues and Confounders
Q1: What guidance can be offered with respect to selecting and measuring potential confounders? What criteria should be applied when selecting control
variables for inclusion in a multivariate analysis? How should potential mediating factors be identified and analyzed?
Q2: Are there cultural aspects to neurodevelopmental tests that should be considered before use?
Reporting of Findings
Q1: How is clinical significance versus population significance defined and reported?
Q2: How do researchers address the issue of labeling of children based on study results and how should the study results be reported to parents?
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